Leaders of G20 countries wrapped up their annual gathering, taking place in Indonesia this year, with a strong note that the world should work together to improve the ability to tackle health challenges, propelling the global recovery from the COVID-19 pandemic.

This year's G20 Summit called for the countries to build a global health architecture that helps to address various health issues and help developing economies to better protect themselves from health crisis including COVID-19 and monkeypox.

The bloc has introduced a $1.4 billion fund for worldwide pandemic prevention, which will function as a catalyst for long-term financial resource for recipient countries to boost investment in pandemic prevention. The fund will especially benefit developing economies that lack necessary equipment and talent in fighting pandemics.

"Developing countries must become a part of the global health supply chain, including manufacturing and research centers," Indonesian President Joko Widodo said at the summit on Tuesday.

The health ministers of G20 countries met last month ahead of the Bali meeting to propose a series of actions for this week's summit. They called for further collaborations on the improvement of the travel certificating system and genomic surveillance mechanism, a critical part of the pandemic prevention effort.

China is one of the countries leading the effort to help the world fight against the COVID-19 pandemic.

As the world's second largest economy, China has provided more than 2.2 billion doses of COVID-19 vaccine to over 120 countries and international organizations. The country has also delivered life-saving supplies and medical experts to help the world curb the spread of the coronavirus.

The cooperation between China and Indonesia in vaccine development has continued to deepen as companies from both countries signed agreements during G20. Chinese drug developer CanSino Biologics Inc. said the company will collaborate with Indonesian firms to jointly develop vaccines and help turn the Southeast Asian country into a regional vaccine production center.

COVID-19 vaccines made by Chinese pharmaceutical companies including Sinovac, Sinopharm, CanSino and Walvax Biotechnology have already been approved for use in Indonesia.